Navigation Links
Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
Date:1/14/2014

ctedly fail at any time; (v) patents may not issue from our patent applications for etirinotecan pegol, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (vi) the outcome of any existing or future intellectual property or other litigation related to our proprietary drug candidates. Other important risks and uncertainties are detailed in our reports and other filings with the Securities and Exchange Commission ("SEC"), including without limitation, those risks and uncertainties set forth in our quarterly report on Form 10-Q for the quarter ended September 30, 2013, filed with the SEC on November 7, 2013. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.Nektar Investor and Media Inquiries: Jennifer Ruddock/Nektar Therapeutics

(415) 482-5585Susan Noonan/SA Noonan Communications, LLC

(212) 966-3650Nektar Media Inquiries:  Brianne Cannon(415) 512-0770(1) Awada et al, Lancet Oncology 2013 Nov;14 (12):1216-25.

(2) American Cancer Society, 2007 Global Cancer Facts and Figures Report.

(3) American Cancer Society, 2009 Global Cancer Facts and Figures Report.

(4) Moreno-Aspitia and Perez, Mayo Clin Proc. 2009; 84(6):533-545


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
2. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
3. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
4. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
5. CAS REGISTRY(SM) surpasses 75 million small molecules
6. WuXi Manufacturing Facility Passes FDA Inspection
7. Tecfideras Patient Share at Three Months Postlaunch Surpasses That for Aubagio and Gilenya At the Same Stage of Their Launches
8. Emotivs Brainwear Technology To Track Cognitive Health Surpasses $1M Kickstarter Stretch Goal
9. The Leukemia & Lymphoma Society Co-Pay Assistance Fund Surpasses $200 Million
10. French Man with SynCardia Total Artificial Heart Surpasses Two Years of Support
11. NABPs .PHARMACY Proposal Passes Initial ICANN Evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Children,s National Health ... Sept. 29 at 5 p.m. EDT for its ... in response to continued strong interest from inventors.  ... will be awarded to the winning presentations at ... Symposium hosted by Children,s National in October. For ...
(Date:9/22/2014)... BROOK, N.J. , Sept. 22, 2014 /PRNewswire/ ... antibody therapies to treat infectious disease, today announced ... volunteer safety studies of obiltoxaximab (ETI-204). Obiltoxaximab is ... inhalational anthrax and data from these studies support ... administered intravenously (IV) at the intended therapeutic dose. ...
(Date:9/22/2014)... and SHANGHAI , ... Group (BHG), a global knowledge leader in healthcare ... partnership to support healthcare innovation in ... personal connected health technologies. Continua and BHG announced ... Forum being held this week in ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... ULURU Inc. (NYSE Amex: ULU ) ... discuss the third quarter ended September 30, 2010 financial results ... 12, 2010 at 9:00 a.m. Eastern Time. To ... international callers dial (850) 429-1388 (access code 23699#) five to ...
... GAITHERSBURG, Md., Nov. 8, 2010 GenVec, Inc. (Nasdaq: ... ended September 30, 2010.   GenVec reported a net ... ended September 30, 2010 compared to a net loss of $3.6 ... the nine months ended September 30, 2010, GenVec,s net loss was ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call 2GenVec Reports Third Quarter 2010 Financial Results 2GenVec Reports Third Quarter 2010 Financial Results 3GenVec Reports Third Quarter 2010 Financial Results 4GenVec Reports Third Quarter 2010 Financial Results 5
(Date:9/23/2014)... Névo takes a bold step forward ... adding advanced activity tracking and phone notifications for a ... calories burned, and more. , http://www.nevowatch.com , ... habits in their busy lives to look and feel ... produce healthy results, but until now, style played a ...
(Date:9/23/2014)... Medicine in Motion (MIM) is proud to announce ... W. 38th, Suite G4. After serving the area’s sports medicine ... demand for MIM’s superior care led to the need for ... excited about bringing our high-quality brand of sports medicine to ... Motion. “We’ll continue to provide patients with the same great ...
(Date:9/22/2014)... 2014 The Gesundheit! Institute founded ... design and restructuring for their existing website. The Institute had ... needed a way to navigate to the different branches of ... present the look and feel of the site in a ... when Patch Adams graduated from The Medical School of Virginia, ...
(Date:9/22/2014)... Provo, Utah (PRWEB) September 23, 2014 ... education and corporate training, will be attending and ... of the American Health Information Management Association (AHIMA) ... held September 27 through October 1, and Career ... information on its suite of coding training products, ...
(Date:9/22/2014)... During the annual Oregon Health Care Association ... care and senior housing industry are recognized for their ... of others. , This year, Nicolette Merino, Regional ... awarded the OHCA Special Service Award. This award is ... assist OHCA in reaching strategic objectives or help achieve ...
Breaking Medicine News(10 mins):Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Austin Sports Medicine Practice to Host Grand Opening Event for Second Location 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 3Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Avamere Family of Companies Regional Director Nominated for the Oregon Health Care Association 2014 Special Service Award 2
... Jose "El Nino" Temprana, a 105-year-old exile who was detained for ... when he became a US citizen at a ceremony in Miami. ... find himself a wife. ,And the former fisherman is ... once plotted to assassinate. ,"He's far less healthy than ...
... about it for fourteen years and when he finally started it ... Ark. ,Huibers, a jovial man with a smile ... after having a dream that the Netherlands was flooded. ... I like to talk about God and tell the story," Huibers ...
... your pet could prove bad for your lungs. ... from the cats skin could irritate the lungs and exacerbate ... specific allergy to the animals. Of course the problem is ... kind or another. ,A Europe-wide study by a ...
... visits to hospitals and doctors, new data suggests . ... of increased birth rates, such as those during the economic ... have put the generation's birth years at 1946 to 1964. ... booming, prosperous America, admired and envied by other countries. ...
... issue of The American Journal of Medicine, researchers from ... that people 45 to 64 years of age who ... for cardiovascular disease (CVD) and reduce their death rate. ... eating at least 5 fruits and vegetables daily, exercising ...
... Jammu and Kashmir has allegedly committed suicide in her home ... Razdan of the Engineering Regiment was found hanging by her ... quarters at Kunjwani on the outskirts of this winter capital ... a nearby market area and found the door locked from ...
Cached Medicine News:Health News:The American Dream Comes True for 105-year-old Cuban 2Health News:Dutchman Rebuilds Noah's Ark to Spread His Faith 2Health News:Dutchman Rebuilds Noah's Ark to Spread His Faith 3Health News:Allergic Individuals Should Keep Away from Cats, Say UK Scientists 2Health News:Allergic Individuals Should Keep Away from Cats, Say UK Scientists 3Health News:As the US Population Ages, Hospital and Doctors Visits Shoot Up 2Health News:Healthy Lifestyle can Reduce Cardiovascular Risk 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: